Showing results (611-620 of 992) with videos related to
Sort By:
Pageof 100
Journal of Opioid Management|August 28, 2015
Impact of constipation on opioid therapy management among long-term opioid users, based on a patient surveyShaloo Gupta, Haridarshan Patel, Justin Scopel, et al.Journal of Opioid Management|August 23, 2017
Opioid management strategy decreases admissions in high-utilizing adults with sickle cell diseaseAmy Mager, Kristin Pelot, Kathryn Koch, et al.Journal of Opioid Management|August 23, 2017
Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volumeVictoria Divino, M Soledad Cepeda, Paul Coplan, et al.Journal of Opioid Management|August 23, 2017
Cost of opioid-treated chronic low back pain: Findings from a pilot randomized controlled trial of mindfulness meditation-based interventionAleksandra E Zgierska, James Ircink, Cindy A Burzinski, et al.Journal of Opioid Management|August 23, 2017
Sex differences in the daily rhythmicity of morphine consumption after major abdominal surgeryStefano Cattaneo, Pablo Ingelmo, Luigia Scudeller, et al.Journal of Opioid Management|August 23, 2017
A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implicationsCorey J Hayes, Jacob T PainterJournal of Opioid Management|January 9, 2018
Interpreting labels of abuse-deterrent opioid analgesicsLynn R WebsterJournal of Opioid Management|January 9, 2018
Abuse-deterrent features of an extended-release morphine drug product developed using a novel injection-molding technology for oral drug deliveryNikolaj Skak, Torben Elhauge, Jeffrey M Dayno, et al.Journal of Opioid Management|January 9, 2018
Application of hot-melt extrusion technology in immediate-release abuse-deterrent formulationsKlaus Wening, Sebastian Schwier, Hans-J Stahlberg, et al.Journal of Opioid Management|January 11, 2019
A claims analysis of the utilization of tramadol for acute pain in patients prescribed buprenorphine/naloxone for opioid use disorderKellye Donovan, Stephen Kogut, Ashley Buchanan, et al.Pageof 100